Anacor Pharmaceuticals Awarded $13.5M in Research Agreement with Defense Threat Reduction Agency
October 21, 2013 at 09:14 AM EDT
Anacor Pharmaceuticals (NASDAQ: ANAC ) today announced it has entered into a research agreement with the United States Department of Defense, Defense Threat Reduction Agency (DTRA) to design and discover new
